BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11201744)

  • 21. The role of Janus kinases in haemopoiesis and haematological malignancy.
    Khwaja A
    Br J Haematol; 2006 Aug; 134(4):366-84. PubMed ID: 16822289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
    Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
    Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
    Pathak MK; Yi T
    J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
    Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
    Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
    Nosaka T; Kitamura T
    Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
    Callus BA; Mathey-Prevot B
    Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
    Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
    Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.
    Aznar S; Valerón PF; del Rincon SV; Pérez LF; Perona R; Lacal JC
    Mol Biol Cell; 2001 Oct; 12(10):3282-94. PubMed ID: 11598209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.
    Björnström L; Sjöberg M
    Mol Endocrinol; 2002 Oct; 16(10):2202-14. PubMed ID: 12351686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes.
    Xue HH; Kovanen PE; Pise-Masison CA; Berg M; Radovich MF; Brady JN; Leonard WJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13759-64. PubMed ID: 12354940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein phosphatase 1alpha is tyrosine-phosphorylated and inactivated by peroxynitrite in erythrocytes through the src family kinase fgr.
    Mallozzi C; De Franceschi L; Brugnara C; Di Stasi AM
    Free Radic Biol Med; 2005 Jun; 38(12):1625-36. PubMed ID: 15917191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells.
    Tagaya Y; Burton JD; Miyamoto Y; Waldmann TA
    EMBO J; 1996 Sep; 15(18):4928-39. PubMed ID: 8890166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus.
    Avota E; Avots A; Niewiesk S; Kane LP; Bommhardt U; ter Meulen V; Schneider-Schaulies S
    Nat Med; 2001 Jun; 7(6):725-31. PubMed ID: 11385511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAKs, STATs and Src kinases in hematopoiesis.
    Rane SG; Reddy EP
    Oncogene; 2002 May; 21(21):3334-58. PubMed ID: 12032773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-type PB-cadherin promotes survival of gonocytes and activates JAK-STAT signalling.
    Wu J; Jester WF; Orth JM
    Dev Biol; 2005 Aug; 284(2):437-50. PubMed ID: 16038895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.
    Witthuhn BA; Silvennoinen O; Miura O; Lai KS; Cwik C; Liu ET; Ihle JN
    Nature; 1994 Jul; 370(6485):153-7. PubMed ID: 8022486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
    Millot GA; Vainchenker W; Duménil D; Svinarchuk F
    Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: inhibition of proliferation without induction of apoptosis.
    Blank N; Kriegel M; Hieronymus T; Geiler T; Winkler S; Kalden JR; Lorenz HM
    J Immunol; 2001 May; 166(10):6034-40. PubMed ID: 11342620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.
    Groner B; Fritsche M; Stöcklin E; Berchtold S; Merkle C; Moriggl R; Pfitzner E
    Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S15-20. PubMed ID: 10984248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive and negative regulation of T-cell activation through kinases and phosphatases.
    Mustelin T; Taskén K
    Biochem J; 2003 Apr; 371(Pt 1):15-27. PubMed ID: 12485116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.